Contraception: latest news

Contraception resources

Contraception features

Contraception news from aidsmap

More news

Contraception news selected from other sources

  • As strategies to prevent HIV and unintended pregnancies evolve, concepts of “multi-purpose technologies” raise a familiar question . . .

    What do women want? While two trials test vaginal rings to fight HIV, market research highlights respondents’ interests in different options.

    14 November 2014 | Science Speaks
  • Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

    University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

    04 November 2014 | Healthline News
  • Oral contraception may become renewed option for HIV-positive women

    Contrary to guidelines issued by the World Health Organization, new research has found that HIV-positive women receiving one of the most common forms of drug therapy should be able to use at least some forms of oral contraceptives for birth control.

    30 October 2014 | Oregon State University
  • PrEP, The Pill, and the Fear of Promiscuity

    LGBT academic Ian Lekus compares the furore around PrEP with the one that met the development of the contraceptive pill: "Acknowledged or not, PrEP users — and for that matter, three decades-plus of HIV/AIDS activism — build directly on how the Pill’s early adopters challenged the presumed omniscience of medical authorities. The experiences of the Pill’s first users also remind us to keep a critical eye trained on those institutions and narratives that circumscribe the quest for balancing health, desire, and autonomy."

    25 September 2014 | Nursing Clio
  • Advocates Call for Full Funding of Research on HIV and Contraception

    We call on the donors to ensure the ECHO trial is fully funded without additional budget cuts or delays. ECHO is a randomized clinical trial that would look at whether the three options—Depo, Jadelle, and the copper intrauterine device—affect HIV-negative women’s risk of acquiring HIV.

    15 September 2014 | RH Reality Check
  • The Weakest Link of HIV Prevention in Africa – Contraception

    In the rush to save babies from HIV infection and treat their mothers, experts warn that a key element of HIV prevention is being neglected in Africa – contraceptives for HIV positive women.

    15 August 2014 | Inter Press Service
  • One in four HIV-positive women in Central America pressured to sterilise - study

    HIV-positive women in Central America are being pressured to undergo sterilisation by prejudiced health workers and misled about the risk of the virus being transmitted to their unborn children, a study showed.

    23 July 2014 | Thomson Reuters
  • 'Remote control' contraceptive chip available 'by 2018'

    A contraceptive computer chip that can be controlled by remote control has been developed in Massachusetts. The chip is implanted under a woman's skin, releasing a small dose of levonorgestrel, a hormone.

    08 July 2014 | BBC
  • Unsafe sex: why everyone's at it

    They pay their bills, hold down careers – so why are young people taking risks when it comes to sex? We talk to the women (and men) ditching contraception and trusting in luck.

    24 May 2014 | The Guardian
  • Study comparing injectable contraceptives DMPA and NET-EN finds HIV risk higher with DMPA

    Women who used an injectable contraceptive called DMPA were more likely to acquire HIV than women using a similar product called NET-EN, according to a secondary analysis of data from a large HIV prevention trial called VOICE. The new analysis, conducted by researchers from the NIH-funded Microbicide Trials Network, is the first head-to-head observational study to directly compare differences in HIV risk between users of DMPA and NET-EN.

    04 March 2014 | Eurekalert Medicine & Health
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also